Vibrational Spectroscopy: A Valuable Screening and Diagnostic Tool for Obstetric Disorders?

Area of Science:

• Obstetrics and Gynecology
• Biomedical Engineering
• Analytical Chemistry

Background:

• Preeclampsia (PE) affects 2-8% of pregnancies, causing severe maternal and fetal outcomes, particularly in low-middle income countries (LMICs).
• Current PE screening relies on nonspecific maternal factors, with advanced biomarker algorithms being costly and unavailable in LMICs.
• Novel, accessible screening methods are urgently needed to address the limitations of existing PE detection strategies.

Purpose of the Study:

• To review current alternative screening methods for preeclampsia.
• To introduce vibrational spectroscopy (Raman and FTIR) as a novel screening and diagnostic tool for obstetric disorders.
• To highlight the potential of vibrational spectroscopy in resource-limited settings.

Main Methods:

• Review of current literature on preeclampsia screening alternatives.
• Introduction to Raman spectroscopy and Fourier-transform infrared spectroscopy (FTIR) principles.
• Discussion of the application of vibrational spectroscopy in obstetric care.

Main Results:

• Existing screening methods for preeclampsia lack specificity and are often inaccessible in LMICs.
• Vibrational spectroscopy techniques offer detailed molecular analysis, creating unique "fingerprints" for diseased states.
• These methods require no specialized reagents and can be adapted to portable platforms suitable for diverse settings.

Conclusions:

• Vibrational spectroscopy presents a superior alternative for preeclampsia screening and diagnosis compared to current methods.
• Its adaptability to portable platforms and lack of reagent requirements make it ideal for LMICs.
• This technology holds potential for broader applications in diagnosing other obstetric conditions like gestational diabetes mellitus and obstetric cholestasis.